Bacteriocin-transport–inspired oral peptide-probiotic delivery ameliorates IBD complications via autophagy and gut homeostasis
Science Advances · 02.01.2026 · 12 (1)
DOI: 10.1126/sciadv.adz9069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 02.01.2026. Verfasst von Yang Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Autophagy, Bacteriocins, Probiotics. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Medical Science and Technology Project of Zhejiang Province, National Key R&D Program of China.
Abstract (Originalsprache)
Intestinal fibrosis (IF), a severe complication of inflammatory bowel disease (IBD), remains a critical unmet clinical need. Although the LL37 peptide and probiotics demonstrate therapeutic potential against IF, their clinical translation is hampered by enzymatic hydrolysis and rapid clearance. Here, inspired by the strategy of bacteriocin transport by bacteria (BTB), we developed an orally administered biotherapeutic platform [BTB–alginate (Alg)] featuring an “all-in-one” architecture that enables spatiotemporal coordination of LL37 and probiotics. The BTB-Alg effectively restored intestinal homeostasis through inflammation resolution, immune modulation, and gut microbiota reconstitution. Notably, integrated multiomics analysis and molecular dynamics simulations revealed that LL37 exerts antifibrotic effects by inducing adenosine 5′-monophosphate–activated protein kinase/mammalian target of rapamycin–mediated autophagy, a mechanism validated in clinical specimens. BTB-Alg exhibited potent therapeutic efficacy in three murine models of acute colitis, IBD-associated IF, and Clostridioides difficile –complicated colitis, highlighting its potential as an IBD treatment paradigm. This study offers a clinically translatable strategy for broad gastrointestinal applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
- College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
- Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
- Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
- School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 999077, China.
ORCID-Profile: Yang Yu, Yuting Bu, Chao Shen, Bingru Lin, Zhe Shen, Chong Li, Xin Li
Förderung
- National Natural Science Foundation of China
- Medical Science and Technology Project of Zhejiang Province
- National Key R&D Program of China
- Chongqing Science Fund for Distinguished Young Scholars
- Chongqing University Innovation Research Group
Zitieren
APA
Yu, Y., Bu, Y., Shen, C., Lin, B., Lu, C., Zhu, L., Shen, Z., Li, C., & Li, X. (2026). Bacteriocin-transport–inspired oral peptide-probiotic delivery ameliorates IBD complications via autophagy and gut homeostasis. Science Advances, 12(1). https://doi.org/10.1126/sciadv.adz9069
Vancouver
Yu Y, Bu Y, Shen C, Lin B, Lu C, Zhu L, et al. Bacteriocin-transport–inspired oral peptide-probiotic delivery ameliorates IBD complications via autophagy and gut homeostasis. Science Advances. 2026;12(1). doi:10.1126/sciadv.adz9069
BibTeX
@article{Yu2026,
author = {Yu, Yang and Bu, Yuting and Shen, Chao and Lin, Bingru and Lu, Chao and Zhu, Lin and Shen, Zhe and Li, Chong and Li, Xin},
title = {Bacteriocin-transport–inspired oral peptide-probiotic delivery ameliorates IBD complications via autophagy and gut homeostasis},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {1},
doi = {10.1126/sciadv.adz9069}
}
EUVIMED